Emerald Acquisition’s Cardiovascular Systems, Inc. CSII Stock Holding History

Emerald Acquisition’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$741K	Buy	+31,193	New	+$683K	﹤0.01%	2272

Other funds holding CSII

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Emerald Acquisition's CSII Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Cardiovascular Systems, Inc. (CSII) in Q3 2016: 31,193 shares worth $741K. The stake represents ﹤0.01% of the portfolio and ranks #2272 among its holdings.

138 funds tracked by Wall St. Rank hold CSII as of Q3 2016.

Emerald Acquisition held 31,193 shares of Cardiovascular Systems, Inc. worth $741K as of Q3 2016.
Cardiovascular Systems, Inc. was a new Emerald Acquisition position in Q3 2016.
Cardiovascular Systems, Inc. made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2272 holding.
138 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.